Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
228.50    0.50 (0.22%)
Bid:
228.50
Ask:
229.50
Spread: 1.00 (0.438%)
Market Cap: £631.61m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Trading Update

4 Nov 2022 07:00

RNS Number : 2795F
Morgan Advanced Materials PLC
04 November 2022
 

 

Press Release

Morgan Advanced Materials plc

4 November 2022

Trading Update

Morgan Advanced Materials plc, the global manufacturer of advanced carbon and ceramic materials for complex and technologically demanding applications, announces today its scheduled trading update for the first nine months to 30 September 2022.

Current Trading

Sales for the nine months to September 2022 were 10.5% higher for the Group, on an organic constant-currency basis, compared with the same period last year.

By business unit, organic constant-currency sales performance for the nine months to September 2022, compared with the same period last year, were as follows:

Thermal Ceramics +10.7%

Molten Metal Systems +17.4%

Electrical Carbon +7.2%

Seals and Bearings +6.9%

Technical Ceramics +13.0%

Group +10.5%

Outlook

Our revenue growth has remained robust. Despite having seen the expected slight moderation of growth rates in our third quarter, reflecting challenges in the wider economy, we now expect our full year organic constant-currency growth to be in the range 7-9%, above our previous guidance. We expect adjusted operating profit for full year 2022 to be marginally above the top end of current analysts' forecasts.

Pete Raby, Chief Executive Officer, said:

"We are delivering robust revenue growth, despite the challenging environment, and improving profitability, with inflation continuing to be more than offset by pricing and continuous improvement activity".

Upcoming events

A capital markets event for institutional investors and analysts will be held on 6 December 2022 in London. Pete Raby and Richard Armitage will be joined by senior leaders from across the group for a series of presentations covering our strategic progress, faster growing market opportunities, ESG approach and the group's financial and M&A framework and aspirations. The slides will be available on the group's website.

The full year results are expected to be released on 28 February 2023.

For further enquiries:

Pete Raby Morgan Advanced Materials plc 01753 837000

Richard Armitage

Nina Coad Brunswick 0207 404 5959

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDXLFBLFLBFBX
Date   Source Headline
30th Nov 20113:26 pmRNSScrip Dividend Price
30th Nov 20111:16 pmRNSHolding(s) in Company
29th Nov 20114:06 pmRNSHolding(s) in Company
25th Nov 20119:41 amRNSDirector/PDMR Shareholding
14th Nov 20117:00 amRNSInterim Management Statement
18th Oct 20119:29 amRNSHolding(s) in Company
5th Oct 20115:50 pmRNSHolding(s) in Company
4th Oct 20119:57 amRNSDirector/PDMR Shareholding
12th Sep 201112:16 pmRNSDirector/PDMR Shareholding
31st Aug 20114:08 pmRNSHolding(s) in Company
24th Aug 201112:33 pmRNSDirector/PDMR Shareholding
11th Aug 20119:45 amRNSHalf Yearly Report
1st Aug 20119:35 amRNSTotal Voting Rights
20th Jul 20113:10 pmRNSDirector/PDMR Shareholding
13th Jul 20117:00 amRNSTrading Statement
8th Jul 20115:40 pmRNSDirector/PDMR Shareholding
8th Jul 20115:27 pmRNSTotal Voting Rights
1st Jul 201111:06 amRNSIssue of Equity
15th Jun 201112:03 pmRNSBlocklisting Interim Review
25th May 20119:57 amRNSScrip Dividend Price
11th May 20113:32 pmRNSResult of AGM
10th May 20117:00 amRNSInterim Management Statement
18th Apr 20112:59 pmRNSAnnual Information Update
8th Apr 20113:30 pmRNSDirector/PDMR Shareholding
8th Apr 201112:23 pmRNSHolding(s) in Company
8th Apr 201112:21 pmRNSDirector/PDMR Shareholding
6th Apr 20115:00 pmRNSDirector/PDMR Shareholding
31st Mar 20117:00 amRNSAnnual Financial Report
31st Mar 20117:00 amRNSCapital Markets Presentation
25th Mar 20114:01 pmRNSHolding(s) in Company
25th Mar 20113:57 pmRNSDirector/PDMR Shareholding
24th Mar 20115:10 pmRNSDirector/PDMR Shareholding
24th Mar 20113:03 pmRNSDirector/PDMR Shareholding
15th Mar 20116:00 pmRNSHolding(s) in Company
15th Mar 20115:58 pmRNSHolding(s) in Company
4th Mar 20115:09 pmRNSDirector/PDMR Shareholding
28th Feb 20115:27 pmRNSTotal Voting Rights
16th Feb 20117:00 amRNSFull Year Results
31st Jan 201110:26 amRNSTotal Voting Rights
28th Jan 20111:33 pmRNSAppointment as a Non-Executive Director
17th Jan 20113:20 pmRNSHolding(s) in Company
17th Jan 20113:20 pmRNSDirector/PDMR Shareholding
14th Jan 20117:00 amRNSAcquisition
13th Jan 201110:15 amRNSAppointment of Tim Stevenson to Johnson Matthey
12th Jan 20111:21 pmRNSHolding(s) in Company
12th Jan 20119:34 amRNSDirector/PDMR Shareholding
12th Jan 20119:30 amRNSTotal Voting Rights
5th Jan 201110:40 amRNSIssue of Shares under Scrip Dividend Scheme
15th Dec 20104:04 pmRNSBlocklisting Interim Review
8th Dec 20104:07 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.